Janeth Castano

Janeth Castano

Auto-generated profile, based on publicly available information

Janeth Castano

Department of Emergency Medicine, Indiana University School of Medicine , 720 Eskenazi Ave, 3rd floor, Indianapolis, IN 46202

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 April 2025 in Food and Agricultural Immunology
Verified
Journal Article
Open access
RSRosario Suarez
Rosario Suarez
EBEstefanía Bautista-Valarezo
Estefanía Bautista-Valarezo
AMAndri Matos
Andri Matos
PCPaula Calderón
Paula Calderón
FFFederica Fascì-Spurio
Federica Fascì-Spurio
Evelyn Frias-ToralEvelyn Frias-Toral
Evelyn Frias-Toral

6 May 2025 in Food and Agricultural Immunology
Verified
Journal Article
Open access
CRClaudia Reytor-González
Claudia Reytor-González
DSDaniel Simancas-Racines
Daniel Simancas-Racines
MCMartín Campuzano
Martín Campuzano
JJJaneth Castano Jimenez
Janeth Castano Jimenez
NRNáthaly Mercedes Román-Galeano
Náthaly Mercedes Román-Galeano
Evelyn Frias-ToralEvelyn Frias-Toral
Evelyn Frias-Toral

31 March 2025 in Brain Sciences
Verified
Journal Article
Open access
PDF file
SCSebastián Pablo Chapela
Sebastián Pablo Chapela
Ludwig Roberto Álvarez-CórdovaLudwig Roberto Álvarez-Córdova
Ludwig Roberto Álvarez-Córdova
AMAndres Luciano Nicolas Martinuzzi
Andres Luciano Nicolas Martinuzzi
RSRosario Suarez
Rosario Suarez
VGVictoria Carolina Gonzalez
Victoria Carolina Gonzalez
LSLuigi Schiavo
Luigi Schiavo
Bariatric surgery (BS) is an effective intervention for obesity, inducing significant neurobiological and gut microbiota changes that influence hunger, appetite, taste perception, and long-term metabolic health. This narrative review examines these alterations by analyzing recent findings from clinical and preclinical studies, including neuroimaging, microbiome sequencing, and hormonal assessments. BS modulates appetite-regulating hormones, reducing ghrelin while increasing glucagon-like peptide-1 (GLP-1) and peptide tyrosine-tyrosine (PYY), leading to enhanced satiety and decreased caloric intake. Neuroimaging studies reveal structural and functional changes in brain regions involved in reward processing and cognitive control, contributing to reduced cravings and altered food choices. Additionally, BS reshapes the gut microbiota, increasing beneficial species such as Akkermansia muciniphila, which influence metabolic pathways through short-chain fatty acid production and bile acid metabolism. These findings highlight the complex interplay between the gut and the brain in post-surgical metabolic regulation. Understanding these mechanisms is essential for optimizing post-operative care, including nutritional strategies and behavioral interventions. Future research should explore how these changes impact long-term outcomes, guiding the development of targeted therapies to enhance the recovery and quality of life for BS patients.

10 May 2023 in Cytotherapy
Verified
Journal Article
Closed access
ALA. López-Fernández
A. López-Fernández
MCMargarita Codinach
Margarita Codinach
MCM. Coca
M. Coca
JCJ. Castaño
J. Castaño
CPCristina Prat-Vidal
Cristina Prat-Vidal
JVJoaquim Vives
Joaquim Vives

24 September 2026 in American Journal of Health-System Pharmacy
Verified
Journal Article
Closed access
DKDiane Kuhn
Diane Kuhn
ECErika R. Cheng
Erika R. Cheng
NSNithika Sanghi
Nithika Sanghi
TWTerri Wada
Terri Wada
JCJaneth Castano
Janeth Castano
PMPaul I Musey
Paul I Musey
Background: Hypertension contributes substantially to morbidity and mortality, yet patients who rely on the emergency department (ED) may experience gaps in blood pressure management. Although pharmacist-led hypertension programs can improve blood pressure, little is known about ED patients’ perspectives. We explored patient perspectives regarding the acceptability of pharmacist-led hypertension management after ED discharge. Methods: We conducted a qualitative study of adults presenting to an urban academic ED from September–December 2025 with likely undiagnosed or undertreated hypertension. Semi-structured interviews examined experiences managing hypertension, communication preferences, and perspectives on pharmacist-led follow-up. Transcripts underwent thematic analysis incorporating deductive and inductive coding. Results: Eleven participants completed interviews. Four themes were identified: limited hypertension-related communication and knowledge gaps, technology mitigating barriers to blood pressure management, pharmacists’ expertise and scope, and the importance of rapport and accessibility. Participants described competing responsibilities, time constraints, and limited discussion of hypertension during ED visits. Many favored technology-enabled communication and home monitoring. Most viewed pharmacist-led follow-up favorably because of pharmacists’ medication expertise and accessibility, but some expressed uncertainty about pharmacists’ clinical training, prescribing authority, and accountability. Participants also valued continuity and collaboration between pharmacists and physicians. Conclusion: In this small sample, most participants viewed pharmacist-led hypertension management after ED discharge favorably while identifying factors that may affect acceptance. Programs should clearly communicate pharmacists’ qualifications and scope, make physician collaboration visible, and balance convenient technology-enabled care with relational continuity.